Get the Stockscreener App
33.05
0.76%
0.25
Metsera Inc stock is traded at $33.05, with a volume of 1.24M.
It is up +0.76% in the last 24 hours and down -16.22% over the past month.
Metsera Inc is a clinical-stage biotechnology company developing next-generation injectable and oral nutrient-stimulated hormone (NuSH) analog peptides to treat obesity, overweight, and related conditions. The Company has developed and is implementing proprietary methods and platform technologies to advance a broad, scalable, and combinable portfolio of injectable and oral NuSH analog peptides with the potential to address not only the limitations of approved therapies but also many of the anticipated limitations of next-generation therapies in development. The Company uses its proprietary MINT peptide library of NuSH analog peptides alongside its Half-life Augmentation by Lipid Optimization half-life extending platform.
See More
Previous Close:
$32.80
Open:
$33.01
24h Volume:
1.24M
Relative Volume:
1.12
Market Cap:
$3.47B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+6.13%
1M Performance:
-16.22%
6M Performance:
+4.42%
1Y Performance:
+0.00%
1-Day Range:
$33.00
$34.54
1-Week Range:
$29.19
$34.54
52-Week Range:
$12.30
$47.40
Metsera Inc Stock (MTSR) Company Profile
Name
Metsera Inc
Sector
Industry
Phone
(212) 784-6595
Address
3 WORLD TRADE CENTER, NEW YORK
Compare MTSR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MTSR
Metsera Inc
|
33.05 | 3.40B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Metsera Inc Stock (MTSR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-20-25 | Initiated | Wells Fargo | Overweight |
| Feb-25-25 | Initiated | BofA Securities | Buy |
| Feb-25-25 | Initiated | Evercore ISI | Outperform |
| Feb-25-25 | Initiated | Guggenheim | Buy |
Metsera Inc Stock (MTSR) Latest News
Metsera’s (MTSR) Amylin Agonist Data Leads to Price Target Increase - Insider Monkey
Analyzing drawdowns of Metsera Inc. with statistical toolsJuly 2025 Decliners & Advanced Technical Signal Analysis - Newser
Regression analysis insights on Metsera Inc. performanceCEO Change & High Return Trade Opportunity Guides - Newser
Is Metsera Inc. meeting your algorithmic filter criteriaMarket Movers & Accurate Intraday Trade Tips - Newser
Understanding Metsera Inc.’s price movementJuly 2025 Catalysts & Weekly Momentum Picks - Newser
Metsera Inc. Stages Intraday Comeback — Trend Change2025 Technical Patterns & Community Consensus Trade Signals - beatles.ru
Market reaction to Metsera Inc.’s recent newsMarket Volume Report & Capital Efficient Trade Techniques - Newser
Biopharma IPO drought continues: chance of rain expected? - BioWorld MedTech
How high can Metsera Inc. stock goJuly 2025 Sentiment & Fast Gain Swing Alerts - Newser
Statistical indicators supporting Metsera Inc.’s strengthLong Setup & Risk Controlled Daily Trade Plans - Newser
Published on: 2025-08-19 03:03:18 - Newser
What makes Metsera Inc. stock price move sharplyJuly 2025 Levels & Weekly High Momentum Picks - Newser
Chart based analysis of Metsera Inc. trendsExit Point & Pattern Based Trade Signal System - Newser
Technical analysis overview for Metsera Inc. stockTrade Volume Report & Free Weekly Chart Analysis and Trade Guides - Newser
Comparing Metsera Inc. in custom built stock radarsMarket Risk Report & Weekly High Return Stock Opportunities - Newser
Short interest data insights for Metsera Inc.Share Buyback & Safe Entry Point Alerts - Newser
Measuring Metsera Inc.’s beta against major indicesMarket Trend Summary & Consistent Profit Trade Alerts - Newser
Custom watchlist performance reports with Metsera Inc.2025 Historical Comparison & Real-Time Stock Entry Alerts - Newser
Why Metsera Inc. stock attracts strong analyst attentionEarnings Miss & Verified Short-Term Plans - thegnnews.com
Price Action Confirms Reversal in Metsera Inc. TrendJuly 2025 Final Week & Reliable Intraday Trade Plans - newsyoung.net
SoftBank Group's Q2 Portfolio Changes: New Stakes in Metsera and eToro, Reduced Lemonade Holding - AInvest
SoftBank adds new Metsera, eToro stakes, pares Lemonade holding, among Q2 trades (SFTBF:Pink Limited Info) - Seeking Alpha
Sector Leaders Rotate Capital Into Metsera Inc.2025 Valuation Update & AI Powered Trade Plan Recommendations - beatles.ru
Should I set a stop loss on Metsera Inc.2025 Retail Activity & Safe Capital Preservation Plans - thegnnews.com
Sector ETF Data Correlates with Strength in Metsera Inc.Secure Return Focused Investment Plan Released - beatles.ru
Metsera Inc (MTSR) Six Month Summary: The Bright Spot in a Quiet Biotech Year - Smartkarma
Metsera, Inc. Reports Q2 2025 Financial Progress - The Globe and Mail
Can Metsera Inc. hit a new high this monthFree Risk Adjusted Technical Entry Plan - Newser
Watch for Bullish Crossover in Metsera Inc.Quick Gain Stock Watch With Indicators Reviewed - metal.it
Using portfolio simulators with Metsera Inc. includedHigh Conviction Screener with Trend Matching - Newser
What is Metsera Inc. company’s growth strategyPhenomenal trading returns - Jammu Links News
What are the latest earnings results for Metsera Inc.Unlock your portfolio’s hidden potential - Jammu Links News
Why is Metsera Inc. stock attracting strong analyst attentionUnlock expert insights for smarter investing - Jammu Links News
How volatile is Metsera Inc. stock compared to the marketBuild a diversified portfolio for risk mitigation - Jammu Links News
Is it the right time to buy Metsera Inc. stockFree Stock Market Beginners Guide - Jammu Links News
What are Metsera Inc. company’s key revenue driversUnlock powerful trading techniques - Jammu Links News
What are analysts’ price targets for Metsera Inc. in the next 12 monthsBreakthrough financial growth - Jammu Links News
What catalysts could drive Metsera Inc. stock higher in 2025Get timely alerts on market opportunities - Jammu Links News
Is Metsera Inc. a growth stock or a value stockGet exclusive market analysis for investors - Jammu Links News
How strong is Metsera Inc. company’s balance sheetBuild wealth with high-performing stocks - Jammu Links News
Cantor Fitzgerald Forecasts Reduced Earnings for Metsera - Defense World
We're Hopeful That Metsera (NASDAQ:MTSR) Will Use Its Cash Wisely - 富途牛牛
Metsera Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingDay Trading Signals With High Precision Reviewed - metal.it
Metsera, Inc. shares fall 1.51% premarket due to lock-up agreement ending on 30-JUL-2025. - AInvest
Metsera, Inc. Lock-Up Agreement Expiration: 30-JUL-2025 - AInvest
Metsera stock rating reiterated by Cantor Fitzgerald ahead of key updates - Investing.com Nigeria
Metsera Inc Stock (MTSR) Financials Data
There is no financial data for Metsera Inc (MTSR). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Metsera Inc Stock (MTSR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| BERNS PAUL L | Director |
Feb 03 '25 |
Buy |
18.00 |
789,998 |
14,219,964 |
8,313,680 |
| ARCH Venture Partners XII, LLC | 10% Owner |
Feb 03 '25 |
Buy |
18.00 |
2,222,222 |
39,999,996 |
18,503,128 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):